-+ 0.00%
-+ 0.00%
-+ 0.00%

BioMarin is Buying a Rare-Disease Biotech for Nearly $5 Billion. The Stock Is Jumping.

Barron‘s·12/19/2025 15:55:00

登录查看新闻详情